Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1.
Saved in:
| Title: | Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1. |
|---|---|
| Authors: | Gur C; The Lautenberg Center of General and Tumor Immunology, The Hebrew University Hadassah Medical School, Institute for Medical Research Israel-Canada (IMRIC), Jerusalem, Israel., Maalouf N; The Institute of Dental Sciences, The Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel., Shhadeh A; The Institute of Dental Sciences, The Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel., Berhani O; The Lautenberg Center of General and Tumor Immunology, The Hebrew University Hadassah Medical School, Institute for Medical Research Israel-Canada (IMRIC), Jerusalem, Israel., Singer BB; Institut für Anatomie, Universitätsklinikum Essen, Essen, Germany., Bachrach G; The Institute of Dental Sciences, The Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel., Mandelboim O; The Lautenberg Center of General and Tumor Immunology, The Hebrew University Hadassah Medical School, Institute for Medical Research Israel-Canada (IMRIC), Jerusalem, Israel. |
| Source: | Oncoimmunology [Oncoimmunology] 2019 Mar 27; Vol. 8 (6), pp. e1581531. Date of Electronic Publication: 2019 Mar 27 (Print Publication: 2019). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2162-4011 |
|---|---|
| DOI: | 10.1080/2162402X.2019.1581531 |
